Papers of the Week

< BACK TO ARCHIVE

POW ARCHIVE WEEK:
Papers: 27 Mar 2021 - 2 Apr 2021

STUDY TYPE:
Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache

DATE PUBLISHED:
2021 Mar 31

JOURNAL:
Curr Med Res Opin

PUBMED:
http://www.ncbi.nlm.nih.gov/pubmed/33784930?dopt=Abstract

Lasmiditan efficacy in migraine attacks with mild vs. moderate or severe pain.

Authors

Lasmiditan efficacy in migraine attacks with mild vs. moderate or severe pain.

Peres MFP, Vasudeva R, Baygani SK, Dennehy EB, Vincent M, Friedman DI

Curr Med Res Opin. 2021 Mar 31:1.

PMID: 33784930.

Abstract

To evaluate the efficacy of lasmiditan (LTN) in treating migraine attacks of mild vs. moderate or severe pain intensity.

Read This Paper